Literature DB >> 22939317

Characteristics, management of the neck, and oncological outcomes of malignant minor salivary gland tumours in the oral and sinonasal regions.

So-Yoon Lee1, Hyang Ae Shin, Kyung Jin Rho, Hyo Jin Chung, Se-Heon Kim, Eun Chang Choi.   

Abstract

The aim of this study was to evaluate the characteristics of malignant tumours of the minor salivary glands in the oral and sinonasal regions, to make sure that the neck was managed correctly, and to identify oncological outcomes, retrospectively, at a single hospital. A total of 60 patients were reviewed. Forty-nine patients had intraoral lesions and 11 had sinonasal lesions. Of the 60 patients, 28 had stage I to II malignant tumours, and 32 had stage III to IV tumours. Treatment was almost exclusively surgical. One of the 16 patients whose nodes were clinically clear had an elective neck dissection. Adjuvant radiotherapy was given if indicated. The mean follow-up period was 52 months (range 13-190). Sinonasal lesions were all advanced T-stage at diagnosis, had more invaded resection margins, and a higher local recurrence rate than intraoral lesions. There was no regional recurrence in those patients whose nodes were clinically invaded and who had therapeutic neck dissection, or in the patient whose nodes were clinically clear and who had an elective neck dissection. Occult metastases developed exclusively in adenoid cystic carcinomas (ACC), the rate of which was 4/16. Regional recurrence developed in 4 patients who had never had elective treatment to the neck 2 of whom mixed pattern ACC and 2 who had low grade mucoepidermoid carcinomas (MEC). The overall survival was 90% at 2 years, 77% at 5 years, and 74% at 10 years. Sinonasal minor salivary gland tumours require careful follow-up because resection margins are more likely to be invaded by tumour, and they have a higher local recurrence rate than intraoral lesions. Elective neck dissection is needed, particularly for MEC and also to prevent regional recurrence in ACC.
Copyright © 2012 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Malignancy; Minor salivary gland; Neck management; Oral; Sinonasal tract; Survival

Mesh:

Year:  2012        PMID: 22939317     DOI: 10.1016/j.bjoms.2012.05.004

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  7 in total

Review 1.  Cervical lymph node metastasis in adenoid cystic carcinoma of oral cavity and oropharynx: A collective international review.

Authors:  Carlos Suárez; Leon Barnes; Carl E Silver; Juan P Rodrigo; Jatin P Shah; Asterios Triantafyllou; Alessandra Rinaldo; Antonio Cardesa; Karen T Pitman; Luiz P Kowalski; K Thomas Robbins; Henrik Hellquist; Jesus E Medina; Remco de Bree; Robert P Takes; Andrés Coca-Pelaz; Patrick J Bradley; Douglas R Gnepp; Afshin Teymoortash; Primož Strojan; William M Mendenhall; Jean Anderson Eloy; Justin A Bishop; Kenneth O Devaney; Lester D R Thompson; Marc Hamoir; Pieter J Slootweg; Vincent Vander Poorten; Michelle D Williams; Bruce M Wenig; Alena Skálová; Alfio Ferlito
Journal:  Auris Nasus Larynx       Date:  2016-03-24       Impact factor: 1.863

2.  Elective neck dissection in adenoid cystic carcinoma of head and neck: yes or no? A systematic review.

Authors:  Ivica Luksic; Petar Suton
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-03       Impact factor: 2.503

3.  Multi-modality Treatment and Survival in Sinonasal Minor Salivary Gland Tumors.

Authors:  Sina J Torabi; Todd Spock; Bruno Cardoso; Janet Chao; R Peter Manes; Benjamin L Judson
Journal:  J Neurol Surg B Skull Base       Date:  2019-04-01

4.  Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases.

Authors:  Saverio Capodiferro; Giuseppe Ingravallo; Luisa Limongelli; Mauro Giuseppe Mastropasqua; Angela Tempesta; Gianfranco Favia; Eugenio Maiorano
Journal:  J Clin Med       Date:  2020-04-18       Impact factor: 4.241

5.  Transoral endoscopic head and neck surgery (eHNS) for minor salivary gland tumors of the oropharynx.

Authors:  David W Schoppy; Michael E Kupferman; Amy C Hessel; Diana M Bell; Elizabeth M Garland; Edward J Damrose; F Christopher Holsinger
Journal:  Cancers Head Neck       Date:  2017-05-31

Review 6.  Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.

Authors:  Giuditta Mannelli; Lara V Comini; Andrea Sacchetto; Roberto Santoro; Giuseppe Spinelli; Pierluigi Bonomo; Isacco Desideri; Paolo Bossi; Ester Orlandi; Giammarco Alderotti; Alessandro Franchi; Annarita Palomba; Albino Eccher; Daniele Marchioni; Riccardo Nocini; Cesare Piazza; Gabriele Molteni
Journal:  Head Neck       Date:  2022-04-20       Impact factor: 3.821

7.  Prognostic value of primary tumor surgery in minor salivary-gland carcinoma patients with distant metastases at diagnosis: first evidence from a SEER-based study.

Authors:  Xiao Shi; Nai-Si Huang; Rong-Liang Shi; Wen-Jun Wei; Yu-Long Wang; Qing-Hai Ji
Journal:  Cancer Manag Res       Date:  2018-07-20       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.